Skip to content
  • Sample Page

mTOR inhibitor Combined with Irradiation Reduces resistant breast cancer

mTOR inhibitors

mTOR inhibitor Combined with Irradiation Reduces resistant breast cancer

mTOR inhibitors

  • Sample Page

mTOR inhibitor Combined with Irradiation Reduces resistant breast cancer

mTOR inhibitors

Category: Glutamate (EAAT) Transporters

February 24, 2025

Results: Although 34 out of 43 samples (79

October 23, 2024

obtained, analyzed, interpreted, and provided data; A

October 11, 2024

With growing evidence of its use, many adaptations have been made, including modified shorter courses or prolongation of treatment at fixed-dose intervals [6]

October 2, 2024

MEFs assessment

December 8, 2021

The maintenance of dormancy continues to be experimentally attained by increasing the expression of dormancy-related factors also, including p38 MAPK [172], DYRK1A [182,183], and N2RF1 [174,178]

November 3, 2021

Similar to other investigators, we have reported a loss of growth factor responsiveness in fibroblasts isolated from venous ulcer patients indicating that cellular senescence may be involved in CVI dermal pathology 15

© 2025 mTOR inhibitor Combined with Irradiation Reduces resistant breast cancer. Proudly powered by Botiga